{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:12:22Z","timestamp":1791645142542,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00347-024-02073-x","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T12:02:33Z","timestamp":1719403353000},"page":"548-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Endokrine Orbitopathie als Ursache einer Diplopie im Senium\u00a0\u2013 Unterschiede zwischen Jung und Alt","Graves\u2019 orbitopathy as the cause of diplopia in old age\u2014Differences between young and old"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-7689","authenticated-orcid":false,"given":"Michael","family":"Oeverhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"issue":"4","key":"2073_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0002-9394(14)72666-2","volume":"120","author":"GB Bartley","year":"1995","unstructured":"Bartley\u00a0GB et\u00a0al (1995) The incidence of Graves\u2019 ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 120(4):511\u2013517","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2073_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/WNO.0000000000000132","volume":"34","author":"SJ Shan","year":"2014","unstructured":"Shan\u00a0SJ, Douglas\u00a0RS (2014) The pathophysiology of thyroid eye disease. J\u00a0Neuroophthalmol 34(2):177\u2013185","journal-title":"J Neuroophthalmol"},{"issue":"10","key":"2073_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0035-1555762","volume":"47","author":"RS Bahn","year":"2015","unstructured":"Bahn\u00a0RS (2015) Current Insights into the Pathogenesis of Graves\u2019 Ophthalmopathy. Horm Metab Res 47(10):773\u2013778","journal-title":"Horm Metab Res"},{"issue":"1","key":"2073_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","volume":"6","author":"TF Davies","year":"2020","unstructured":"Davies\u00a0TF et\u00a0al (2020) Graves\u2019 disease. Nat Rev Dis Primers 6(1):52","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2073_CR5","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1210\/jc.2016-1315","volume":"101","author":"CC Krieger","year":"2016","unstructured":"Krieger\u00a0CC et\u00a0al (2016) TSH\/IGF\u20111 Receptor Cross Talk in Graves\u2019 Ophthalmopathy Pathogenesis. J\u00a0Clin Endocrinol Metab 101(6):2340\u20132347","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2073_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1089\/thy.2022.0173","volume":"32","author":"YP Hai","year":"2022","unstructured":"Hai\u00a0YP et\u00a0al (2022) A\u00a0Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye. disease Thyroid 32(12):1547\u20131558","journal-title":"disease Thyroid"},{"issue":"6","key":"2073_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1089\/thy.1997.7.885","volume":"7","author":"MN Gerding","year":"1997","unstructured":"Gerding\u00a0MN et\u00a0al (1997) Quality of life in patients with Graves\u2019 ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 7(6):885\u2013889","journal-title":"Thyroid"},{"issue":"6","key":"2073_CR8","first-page":"747","volume":"14","author":"HB Burch","year":"1993","unstructured":"Burch\u00a0HB, Wartofsky\u00a0L (1993) Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 14(6):747\u2013793","journal-title":"Endocr Rev"},{"issue":"2","key":"2073_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1445-5994.1985.tb04021.x","volume":"15","author":"JW Dunne","year":"1985","unstructured":"Dunne\u00a0JW, Edis\u00a0RH (1985) Optic nerve involvement in Graves\u2019 ophthalmopathy: a\u00a0case report and review. Aust N Z J Med 15(2):258\u2013261","journal-title":"Aust N Z J Med"},{"key":"2073_CR10","doi-asserted-by":"crossref","unstructured":"Burch HB, W., Graves\u2019 Ophthalmopathy: Current Concepts Regarding Pathogenesis and Management. The Endocrine Society, 1993. 14(6): p.\u00a0747\u2013783.","DOI":"10.1210\/er.14.6.747"},{"issue":"6","key":"2073_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-18-0039","volume":"178","author":"W Wiersinga","year":"2018","unstructured":"Wiersinga\u00a0W et\u00a0al (2018) Predictive score for the development or progression of Graves\u2019 orbitopathy in patients with newly diagnosed Graves\u2019 hyperthyroidism. Eur J Endocrinol 178(6):635\u2013643","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2073_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/a-1525-2070","volume":"53","author":"M Stohr","year":"2021","unstructured":"Stohr\u00a0M et\u00a0al (2021) Predicting the Course of Graves\u2019 Orbitopathy Using Serially Measured TSH-Receptor Autoantibodies by Automated Binding Immunoassays and the Functional Bioassay. Horm Metab Res 53(7):435\u2013443","journal-title":"Horm Metab Res"},{"issue":"9","key":"2073_CR13","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein\u00a0AK et\u00a0al (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J\u00a0Clin Endocrinol Metab 91(9):3464\u20133470","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2073_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena\u00a0L et\u00a0al (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid\u00a0J 5(1):9\u201326","journal-title":"Eur Thyroid J"},{"issue":"4","key":"2073_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly\u00a0GJ et\u00a0al (2018) 2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism. Eur Thyroid\u00a0J 7(4):167\u2013186","journal-title":"Eur Thyroid J"},{"issue":"4","key":"2073_CR16","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena\u00a0L et\u00a0al (2021) The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185(4):G43\u2013G67","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2073_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archopht.1993.01090020051022","volume":"111","author":"DL Kendler","year":"1993","unstructured":"Kendler\u00a0DL, Lippa\u00a0J, Rootman\u00a0J (1993) The initial clinical characteristics of Graves\u2019 orbitopathy vary with age and sex. Arch Ophthalmol 111(2):197\u2013201","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2073_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","volume":"38","author":"P Perros","year":"1993","unstructured":"Perros\u00a0P et\u00a0al (1993) Age and gender influence the severity of thyroid-associated ophthalmopathy: a\u00a0study of 101 patients attending a\u00a0combined thyroid-eye clinic. Clin Endocrinol (oxf) 38(4):367\u2013372","journal-title":"Clin Endocrinol (oxf)"},{"issue":"6","key":"2073_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1607-551X(08)70154-2","volume":"24","author":"MC Lin","year":"2008","unstructured":"Lin\u00a0MC et\u00a0al (2008) Age influences the severity of Graves\u2019 ophthalmopathy. Kaohsiung J Med Sci 24(6):283\u2013288","journal-title":"Kaohsiung J Med Sci"},{"issue":"6","key":"2073_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/EJE-11-0548","volume":"165","author":"M Abraham-Nordling","year":"2011","unstructured":"Abraham-Nordling\u00a0M et\u00a0al (2011) Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 165(6):899\u2013905","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2073_CR21","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1210\/jc.2012-1275","volume":"97","author":"P Laurberg","year":"2012","unstructured":"Laurberg\u00a0P et\u00a0al (2012) Incidence and clinical presentation of moderate to severe graves\u2019 orbitopathy in a\u00a0Danish population before and after iodine fortification of salt. J\u00a0Clin Endocrinol Metab 97(7):2325\u20132332","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2073_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13023-017-0625-1","volume":"12","author":"P Perros","year":"2017","unstructured":"Perros\u00a0P et\u00a0al (2017) Graves\u2019 orbitopathy as a\u00a0rare disease in Europe: a\u00a0European Group on Graves\u2019 Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis 12(1):72","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2073_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/eje.0.1460153","volume":"146","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard\u00a0P (2002) Smoking and thyroid disorders\u2014a meta-analysis. Eur J Endocrinol 146(2):153\u2013161","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2073_CR24","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1210\/jc.2006-1402","volume":"91","author":"N Manji","year":"2006","unstructured":"Manji\u00a0N et\u00a0al (2006) Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J\u00a0Clin Endocrinol Metab 91(12):4873\u20134880","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2073_CR25","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s00417-015-3156-2","volume":"253","author":"BGJ Simon","year":"2015","unstructured":"Simon\u00a0BGJ et\u00a0al (2015) Age differences in clinical manifestation and prognosis of thyroid eye disease. Graefes Arch Clin Exp Ophthalmol 253(12):2301\u20132308","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"2073_CR26","first-page":"2727","volume":"260","author":"N Levy","year":"2022","unstructured":"Levy\u00a0N et\u00a0al (2022) Clinical profile of 80-year-old and older thyroid eye disease patients. Graefes Arch Clin Exp Ophthalmol 260(8):2727\u20132736","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2073_CR27","doi-asserted-by":"publisher","first-page":"1160172","DOI":"10.3389\/fendo.2023.1160172","volume":"14","author":"M Oeverhaus","year":"2023","unstructured":"Oeverhaus\u00a0M et\u00a0al (2023) Influence of biological sex, age and smoking on Graves\u2019 orbitopathy\u2014a\u00a0ten-year tertiary referral center analysis. Front Endocrinol (lausanne) 14:1160172","journal-title":"Front Endocrinol (lausanne)"},{"key":"2073_CR28","doi-asserted-by":"crossref","unstructured":"Burch, H.B., et\u00a0al., Management of Thyroid Eye Disease: A\u00a0Consensus Statement by the American Thyroid Association and the European Thyroid Association. Thyroid, 2022. 32(12): p.\u00a01439\u20131470.","DOI":"10.1089\/thy.2022.0251"},{"key":"2073_CR29","doi-asserted-by":"crossref","unstructured":"Oeverhaus M et\u00a0al (2024) How Age Affects Graves\u2019 Orbitopathy\u2014A Tertiary Center Study. J\u00a0Clin Med 13(1)","DOI":"10.3390\/jcm13010290"},{"issue":"3","key":"2073_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"GB Bartley","year":"1996","unstructured":"Bartley\u00a0GB et\u00a0al (1996) Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort. Am J Ophthalmol 121(3):284\u2013290","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2073_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00002341-200201000-00003","volume":"18","author":"KP Cockerham","year":"2002","unstructured":"Cockerham\u00a0KP et\u00a0al (2002) Clinicopathologic evaluation of the Mueller muscle in thyroid-associated orbitopathy. Ophthalmic Plast Reconstr Surg 18(1):11\u201317","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"2073_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00417-021-05377-9","volume":"260","author":"Y Su","year":"2022","unstructured":"Su\u00a0Y et\u00a0al (2022) Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves\u2019 orbitopathy. Graefes Arch Clin Exp Ophthalmol 260(2):583\u2013589","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2073_CR33","doi-asserted-by":"crossref","unstructured":"Eckstein, A., et\u00a0al., Surgical Treatment of Diplopia in Graves Orbitopathy Patients. Ophthalmic Plast Reconstr Surg, 2018. 34(4S Suppl 1): p. S75\u2013S84.","DOI":"10.1097\/IOP.0000000000001148"},{"issue":"5","key":"2073_CR34","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00405-021-07003-0","volume":"279","author":"K Stahr","year":"2022","unstructured":"Stahr\u00a0K et\u00a0al (2022) Proposing a\u00a0surgical algorithm for graduated orbital decompression in patients with Graves\u2019 orbitopathy. Eur Arch Otorhinolaryngol 279(5):2401\u20132407","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"( Pt 5): p","key":"2073_CR35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/eye.1998.207","volume":"12","author":"D Paridaens","year":"1998","unstructured":"Paridaens\u00a0D et\u00a0al (1998) The incidence of diplopia following coronal and translid orbital decompression in Graves\u2019 orbitopathy. Eye (Lond) 12(( Pt 5): p):800\u2013805","journal-title":"Eye (Lond)"},{"issue":"e0218701","key":"2073_CR36","first-page":"6","volume":"14","author":"M Oeverhaus","year":"2019","unstructured":"Oeverhaus\u00a0M et\u00a0al (2019) Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves\u2019 orbitopathy. PLoS ONE 14(e0218701):6","journal-title":"PLoS ONE"},{"issue":"1","key":"2073_CR37","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1111\/aos.15223","volume":"101","author":"HM Jellema","year":"2023","unstructured":"Jellema\u00a0HM et\u00a0al (2023) Incidence of A pattern strabismus after inferior rectus recession in patients with Graves\u2019 orbitopathy: A\u00a0retrospective multicentre study. Acta Ophthalmol 101(1):e106\u2013e112","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"2073_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/09273972.2018.1450430","volume":"26","author":"M Oeverhaus","year":"2018","unstructured":"Oeverhaus\u00a0M et\u00a0al (2018) Tendon Elongation with Bovine Pericardium in Patients with Severe Esotropia after Decompression in Graves\u2019 Orbitopathy-efficacy and Long-term Stability. Strabismus 26(2):62\u201370","journal-title":"Strabismus"},{"issue":"4","key":"2073_CR39","first-page":"245","volume":"28","author":"M Nardi","year":"2009","unstructured":"Nardi\u00a0M (2009) Squint surgery in TED\u2014hints and fints, or why Graves\u2019 patients are difficult patients. Orbit 28(4):245\u2013250","journal-title":"Orbit"},{"key":"2073_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajo.2021.11.022","volume":"238","author":"B Hwang","year":"2022","unstructured":"Hwang\u00a0B, Heo\u00a0H, Lambert\u00a0SR (2022) Risk Factors for Reoperation after Strabismus Surgery among Patients with Thyroid Eye Disease. Am J Ophthalmol 238:10\u201315","journal-title":"Am J Ophthalmol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02073-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-024-02073-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02073-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:03:18Z","timestamp":1720094598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-024-02073-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1007\/s00347-024-02073-x","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Oeverhaus, I.\u00a0Neumann, Y.\u00a0Chen und A.\u00a0Eckstein geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}